Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy

Journal of Diabetes Investigation
Shu-Yan LiuYong-Feng Li

Abstract

Recent studies suggest that chronic inflammatory responses are important in the development of diabetic nephropathy (DN). Various inflammatory and angiogenesis molecules affect the pathogenesis and progression of DN. Inflammation damages the microcirculation and causes kidney damage. In the present study, we studied changes in interleukin-8 (IL-8) and soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) levels in patients with DN, and investigated the clinical significance of these two inflammatory factors. Participants were categorized into healthy controls (n = 30) and patients with type 2 diabetes mellitus (n = 124). The type 2 diabetes mellitus group was further subdivided into the normoalbuminuria (n = 34), microalbuminuria (MAU; n = 46,) and proteinuria (MaAU; n = 44,) groups. Patients with DN were included in the MAU and MaAU groups. Total cholesterol, triglyceride, low-density lipoprotein cholesterol, glycosylated hemoglobin, fasting blood glucose, 2-h postprandial blood glucose, blood urea nitrogen, serum creatinine, 24-h urine microalbumin, IL-8 and sTWEAK levels were measured. Logistic regression was used to analyze the factors associated with proteinuria. In the healthy controls, normoalbuminuria, M...Continue Reading

References

Oct 1, 1989·The Journal of Clinical Investigation·M BaggioliniS L Kunkel
Aug 7, 2002·Circulation·Joseph A Vita, John F Keaney
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mariana J KaplanBruce C Richardson
Nov 26, 2002·Journal of Neuroimmunology·Sophie Desplat-JégoJosé Boucraut
Dec 11, 2002·Kidney International·Ricardo UtimuraIrene De Lourdes Noronha
Jun 6, 2003·Cytokine & Growth Factor Reviews·Steven R Wiley, Jeffrey A Winkles
Nov 25, 2004·American Journal of Epidemiology·Alan R DyerUNKNOWN INTERMAP Research Group
Feb 3, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Luis M Blanco-ColioJesús Egido
Apr 12, 2008·Nature Reviews. Drug Discovery·Jeffrey A Winkles
Oct 24, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Juan J CarreroLuis M Blanco-Colio
Sep 30, 2009·Arthritis Research & Therapy·Noa SchwartzChaim Putterman
Oct 31, 2009·European Journal of Heart Failure·Emmanuel ChorianopoulosNorbert Frey
Apr 14, 2010·The Journal of Biological Chemistry·Sharron A N BrownJeffrey A Winkles
Jul 9, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia RoosHarald Wajant
Oct 19, 2012·Clinical Science·Jun Wada, Hirofumi Makino
Mar 12, 2013·Journal of Nephrology·Jose M ValdivielsoLuis M Blanco-Colio
Jun 14, 2013·The Journal of Clinical Endocrinology and Metabolism·Andrés Díaz-LópezJordi Salas-Salvadó
Dec 4, 2015·Journal of Immunology Research·María A HidalgoRafael A Burgos

❮ Previous
Next ❯

Citations

May 31, 2020·International Journal of Molecular Sciences·Sandra Rayego-MateosJesús Egido
Jan 9, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Florian Le BillanJérôme Fagart
Jun 24, 2020·Biochimica Et Biophysica Acta. Proteins and Proteomics·Naseer Ullah KhanLiming Shen

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.